Loading news...
Brown Brothers Harriman and Co. boosted its holdings in shares of Certara, Inc. (NASDAQ: CERT) by 34.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,764,034 shares of the company's stock after acquiring an additional 972,669 shares during the quarter.
2Xideas AG trimmed its holdings in shares of Certara, Inc. (NASDAQ: CERT) by 41.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 184,198 shares of the company's stock after selling 130,568 shares during the period. 2Xideas AG owned approximately 0.12% of Certara worth
Alpha Wave Global LP acquired a new position in Certara, Inc. (NASDAQ: CERT) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 504,724 shares of the company's stock, valued at approximately $6,168,000. Certara accounts for approximately 0.6% of Alpha
Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript
Certara (NASDAQ: CERT) executives used a fireside chat at the TD Cowen Health Care Conference to outline early priorities under new CEO Jon Resnick, discuss the company's ongoing strategic review of its Regulatory Services business, and provide additional context on recent guidance and product momentum. New CEO emphasizes execution, investment focus, and "platform" approach Resnick, who
Certara, Inc. (CERT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
RADNOR, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based pharmacokinetic (PBPK) modeling predictions accepted by the U.S. FDA in lieu of clinical studies to support the new drug application (NDA) for asciminib (Scemblix®).
The Touchstone Small Cap Fund (Class A Shares, Load Waived) outperformed its benchmark, the Russell 2000® Index, for the quarter ended December 31, 2025. The best performing stocks based on relative performance vs. the benchmark during the quarter included White Mountains Insurance Group, Revolve Group Inc. and Haemonetics Corp. The more challenged positions based on relative performance during the quarter included NewMarket Corp., Certara Inc., and Gates Industrial Corp plc.
RADNOR, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
Certara, Inc. (CERT) Q4 2025 Earnings Call Transcript
Certara, Inc. (CERT) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.15 per share a year ago.
FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth Quarter Revenue of $103.6M (3% growth) and Adj.
The London Company Small Cap portfolio increased 2.7% (2.5% net) during the quarter vs. a 2.2% increase in the Russell 2000 Index. Contributors to relative performance were White Mountains Insurance Group Ltd, Revolve Group Inc. and Haemonetics Corporation. Detractors from relative performance were NewMarket Corporation, Certara, Inc. and Gates Industrial Corporation plc.
RADNOR, Pa., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2025 before market open on Thursday, February 26th, 2026.
Shift4 Payments' stock was down after a competitor reported disappointing results, raising concerns for the industry. While Trex Co. is facing some current challenges, we still view Trex as a high-quality business. Fabrinet is seeing increased demand as data centers upgrade their networks to faster and lower-latency communication standards capable of handling complex AI workloads.
Cerrado Gold Inc. (CERT:CA) Discusses Purported Unfavourable Opinion of Environmental Impact Assessment for Lagoa Salgada Project Transcript
Shares of Certara, Inc. (NASDAQ: CERT - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seventeen analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, eight have given a buy rating and two have issued
Shares of Certara, Inc. (NASDAQ: CERT - Get Free Report) gapped up before the market opened on Tuesday after Leerink Partners upgraded the stock from a market perform rating to an outperform rating. The stock had previously closed at $9.04, but opened at $9.43. Leerink Partners now has a $13.00 price target on the stock. Certara
Texas-based Kopion Asset Management added 327,064 Certara shares in the fourth quarter; the estimated transaction size is $3.37 million based on average prices for the quarter. The value of the Certara position rose by $645,681 over the quarter, reflecting both additional shares and price movement.